Deep Track Capital as of March 31, 2023
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 57 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 7.2 | $176M | 1.2M | 146.33 | |
| Iveric Bio | 6.5 | $158M | 6.5M | 24.33 | |
| Travere Therapeutics (TVTX) | 5.7 | $138M | 6.1M | 22.49 | |
| Immunovant (IMVT) | 4.7 | $115M | 7.4M | 15.51 | |
| Insmed Com Par $.01 (INSM) | 4.6 | $111M | 6.5M | 17.05 | |
| Ionis Pharmaceuticals (IONS) | 4.2 | $101M | 2.8M | 35.74 | |
| Intra Cellular Therapies (ITCI) | 3.8 | $92M | 1.7M | 54.15 | |
| Pliant Therapeutics (PLRX) | 3.7 | $91M | 3.4M | 26.60 | |
| Alkermes SHS (ALKS) | 3.5 | $85M | 3.0M | 28.19 | |
| Springworks Therapeutics (SWTX) | 3.3 | $80M | 3.1M | 25.74 | |
| Chinook Therapeutics | 2.9 | $70M | 3.0M | 23.15 | |
| Reata Pharmaceuticals Cl A | 2.7 | $66M | 729k | 90.92 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.6 | $64M | 3.2M | 20.08 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.6 | $63M | 2.6M | 23.79 | |
| Dynavax Technologies Corp Com New (DVAX) | 2.6 | $62M | 6.4M | 9.81 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 2.5 | $60M | 2.8M | 21.27 | |
| Geron Corporation (GERN) | 2.4 | $58M | 27M | 2.17 | |
| Biogen Idec (BIIB) | 2.3 | $56M | 200k | 278.03 | |
| Dice Therapeutics | 1.9 | $46M | 1.6M | 28.65 | |
| Agenus Com New (AGEN) | 1.9 | $46M | 30M | 1.52 | |
| Seagen Put Option | 1.8 | $44M | 218k | 202.47 | |
| Pacific Biosciences of California (PACB) | 1.7 | $41M | 3.5M | 11.58 | |
| 4d Molecular Therapeutics In (FDMT) | 1.6 | $39M | 2.3M | 17.19 | |
| Beam Therapeutics (BEAM) | 1.6 | $38M | 1.3M | 30.62 | |
| Exelixis (EXEL) | 1.5 | $38M | 1.9M | 19.41 | |
| Argenx Se Sponsored Adr Put Option (ARGX) | 1.5 | $37M | 100k | 372.58 | |
| Miragen Therapeutics (VRDN) | 1.3 | $31M | 1.2M | 25.44 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.1 | $28M | 15M | 1.84 | |
| 89bio Put Option (ETNB) | 1.1 | $28M | 1.8M | 15.23 | |
| Dyne Therapeutics (DYN) | 1.1 | $27M | 2.3M | 11.52 | |
| Repare Therapeutics Ord (RPTX) | 1.1 | $27M | 2.7M | 9.84 | |
| Nurix Therapeutics (NRIX) | 1.1 | $27M | 3.0M | 8.88 | |
| Intellia Therapeutics (NTLA) | 1.1 | $26M | 705k | 37.27 | |
| Astria Therapeutics (ATXS) | 1.0 | $24M | 1.8M | 13.30 | |
| Deciphera Pharmaceuticals (DCPH) | 0.9 | $21M | 1.4M | 15.45 | |
| Edgewise Therapeutics (EWTX) | 0.8 | $21M | 3.1M | 6.67 | |
| Vigil Neuroscience (VIGL) | 0.8 | $20M | 2.0M | 9.79 | |
| Inozyme Pharma (INZY) | 0.8 | $19M | 3.3M | 5.73 | |
| Uniqure Nv SHS (QURE) | 0.7 | $17M | 866k | 20.14 | |
| Point Biopharma Global | 0.7 | $17M | 2.3M | 7.27 | |
| Acumen Pharmaceuticals (ABOS) | 0.7 | $16M | 4.0M | 4.06 | |
| Allakos (ALLK) | 0.7 | $16M | 3.6M | 4.45 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $14M | 1.7M | 8.09 | |
| Nuvation Bio Com Cl A (NUVB) | 0.5 | $13M | 7.7M | 1.66 | |
| Silence Therapeutics Ads (SLN) | 0.5 | $12M | 2.0M | 6.20 | |
| Rapt Therapeutics (RAPT) | 0.4 | $11M | 571k | 18.35 | |
| Jounce Therapeutics | 0.3 | $7.9M | 4.3M | 1.85 | |
| Relmada Therapeutics (RLMD) | 0.3 | $6.4M | 2.8M | 2.26 | |
| Orchard Therapeutics Spon Ads New | 0.3 | $6.3M | 1.2M | 5.37 | |
| Heron Therapeutics (HRTX) | 0.2 | $4.9M | 3.2M | 1.51 | |
| Nkarta (NKTX) | 0.2 | $4.8M | 1.4M | 3.55 | |
| Gh Research Ordinary Shares (GHRS) | 0.2 | $4.0M | 499k | 7.99 | |
| Immunic (IMUX) | 0.2 | $3.8M | 2.5M | 1.49 | |
| 2seventy Bio Common Stock (TSVT) | 0.1 | $3.6M | 350k | 10.20 | |
| Century Therapeutics (IPSC) | 0.1 | $3.5M | 1.0M | 3.47 | |
| ImmunoGen Put Option | 0.1 | $1.6M | 428k | 3.84 | |
| Nektar Therapeutics (NKTR) | 0.1 | $1.2M | 1.7M | 0.70 |
